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MATERNAL-FETAL EXCHANGE OF nutrients and respiratory gases
occurs across the brush border of the trophoblast lining the
intervillous space of the placenta. The trophoblast is syncytial
in nature and has a high rate of turnover. Therefore syncy-
tiotrophoblast is continually replenished from an underlying
layer of proliferating stem cells, the villous cytotrophoblasts,
often referred to as Langhan’s layer (Fig. 1). Syncytiotropho-
blast nuclei undergo programmed cell death, and there is strong
evidence that the apoptotic cascade is initiated in the villous
cytotrophoblast (10, 11). The apoptotic nuclei accumulate near
the surface in the “syncytial knots” that are a characteristic of
human placenta. From here, they are shed into the maternal
circulation. They make a sizeable contribution to the cellular
debris of fetal origin that is responsible for the systemic
inflammatory response to pregnancy (17). While such a re-
sponse occurs in normal gestation, it is greatly enhanced in
preeclampsia, an endothelial disorder that is a common and
potentially dangerous complication of pregnancy. Thus an
advance in our comprehension of how these processes are
regulated contributes to our understanding both of trophoblast
biology and of the causes underlying a major pregnancy
disorder. It now appears (5) that trophoblast turnover is regu-
lated, at least in part, by the insulin-like growth factor system.
Insulin-like growth factors I (IGF-I) and II (IGF-II) and their
receptors are known to be important for fetal and placental
growth (4). They are structurally related to insulin and can bind
to insulin receptors. However, most of their effects are exerted
through the IGF type 1 receptor (IGF1R). Interaction between
the growth factors and their receptors is modulated by a family
of six high-affinity binding proteins (IGFBP-1 through -6).
Most of the components of this system are expressed at the
RNA and protein level in human placenta (8). In addition,
IGF-I is synthesized by the liver in response to pituitary and
placental growth hormones and circulates in maternal blood
together with IGFBPs. Finally, both IGF-I and IGF-II are
found in fetal blood, and the binding proteins, especially
IGFBP-1, are synthesized by fetal liver (9) and the uterine
decidua (13).
While it is clear that birth weight and placental weight are
positively correlated with cord blood levels of IGF-I and
IGF-II (6, 16), relatively little is known about how the IGF
system affects growth of the human placenta. Hitherto, the
focus has been on the expression of IGF-II on the extravillous
trophoblast that invades the uterine wall and the expression of
IGFBP-1 and IGFBP-4 on decidual cells (7, 8, 12). Interaction
between IGF-II and IGFBPs at the maternal-fetal interface has
been allotted an important role in limiting trophoblast invasion,
including the subsequent migration of trophoblast to uterine
spiral arteries. Thus it has been suggested that an imbalance in
the IGF system leads to restriction of placental and fetal growth
through restraining trophoblast invasion and decreasing pla-
cental blood flow. In this view, reduced growth of villous
trophoblast is seen as secondary to the reduced supply of
oxygen and nutrients.
Now a well-designed and carefully executed study by Forbes
et al. (5) using first-trimester villous explants convincingly
demonstrates a direct effect of the IGF system on trophoblast
turnover in human placenta. IGF-I and -II enhanced cytotro-
phoblast proliferation and syncytium formation and reduced
cytotrophoblast apoptosis, suggesting a key role for the IGF
system in maintaining the maternal-facing syncytiotrophoblast
layer of the placenta. Importantly, IGF applied to this surface,
mimicking exposure to maternal IGF-I in the intervillous
space, was able to influence proliferation in the underlying
cytotrophoblast layer. The effects on proliferation and syncy-
tium formation were shown to be mediated by the MAPK
pathway, whereas the effects on survival depended on the
phosphoinositide 3-kinase/Akt pathway (5). It is well estab-
lished that these pathways are activated by binding of IGFs to
IGF1R (3), which is expressed on the microvillous membrane
of syncytiotrophoblast.
This new study clearly demonstrates the advantage of using
villous explants, in which the contact between cellular and
syncytial trophoblast is maintained. The two layers are con-
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Fig. 1. Stylized cross section of a placental villus to show trophoblast
turnover in the human placenta. Maternal blood circulates in the intervillous
space. Transfer of nutrients and respiratory gases toward fetal capillaries (fetal
cap) occurs across an outer layer of syncytiotrophoblast (syn troph). It is
constantly replenished from a discontinuous layer of stem cells, the villous
cytotrophoblasts (cyt troph). Even before fusion, the nuclei committed to the
syncytiotrophoblast are programmed for cell death. Apoptotic nuclei from the
aging syncytiotrophoblast accumulate in “syncytial knots” that eventually are shed
into the maternal blood stream. Trophoblast turnover and renewal are tightly
regulated, and it is now apparent that insulin-like growth factors play a key role
in this process.
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nected by gap junctions (2), and there is likely cell signaling
between them. Cytotrophoblast proliferation ceased after the
syncytiotrophoblast layer had been removed (5). Regeneration
of a continuous layer of syncytiotrophoblast occurred within 4
days, and this process was enhanced by application of IGF-I or
IGF-II. This mechanism of tissue damage repair (20) is postu-
lated to involve lateral fusion of a subset of cytotrophoblasts
(5). Much previous effort has been expended on trying to
understand the biology of trophoblast in primary cell culture
and choriocarcinoma cell lines. Primary trophoblasts exit the
cell cycle (15), although they subsequently resume mitosis and
form syncytia. It needs to be addressed whether this is a
process akin to replenishment of syncytiotrophoblast in intact
placental villi or, as seems more likely, is related to the
separate tissue repair mechanism. There is a clear risk that
some conclusions drawn from studies on primary cell culture
as well as choriocarcinoma cell lines are misleading. Indeed,
there is good reason to subscribe to the authors’ view that their
results challenge current models of placental development.
There are even implications for the animal models used to
study trophoblast turnover. In the guinea pig placenta, maternal
blood channels analogous to the intervillous space are lined by
syncytiotrophoblast. During the 2-mo gestation period, growth
and maintenance of the trophoblast occur from nests of highly
proliferative cytotrophoblast (14), much as in human placenta.
Fetal growth restriction in guinea pigs is associated with
altered expression of components of the IGF system (1).
Conversely, exogenous IGF-I and -II stimulate growth of the
placental exchange area (19). The guinea pig may be a useful
model for studying trophoblast turnover and better than the
mouse. In mice, the placental barrier includes three layers of
trophoblast, two of them syncytial. Despite considerable
progress in understanding cell lineages in murine placenta, the
source of the syncytiotrophoblast remains unknown (21). Nor
is it clear whether it is replenished during the relatively short
life of the murine placenta.
There remains much to be learned with the human villous
explant model. Most experiments in the current study were
done in 20% oxygen, with just a few controls in 6% oxygen,
which is closer to the in vivo levels experienced by trophoblast.
The deleterious effect of high oxygen levels on trophoblast
ultrastructure has been known for quite some time (22). More
recently, it was shown in villous explants that high oxygen
levels affect cellular response pathways, including those asso-
ciated with tissue viability and cell death (18). Future protocols
should therefore place greater emphasis on explants cultured at
low oxygen tensions.
Trophoblast turnover and renewal need to be tightly regu-
lated to maintain a bilayered structure while permitting the
placenta to grow in size. It is now evident that insulin-like
growth factors play a key role in promoting this process.
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